-
1
-
-
0031729149
-
Liposomal drug formulation: Rationale for development and what we can expect in the future
-
Allen TM. Liposomal drug formulation: rationale for development and what we can expect in the future. Drugs 1998;56:747-56.
-
(1998)
Drugs
, vol.56
, pp. 747-756
-
-
Allen, T.M.1
-
2
-
-
0347365764
-
An overview of current delivery systems in cancer gene therapy
-
El-Aneed A. An overview of current delivery systems in cancer gene therapy. J Control Release 2004;94:1-14.
-
(2004)
J Control Release
, vol.94
, pp. 1-14
-
-
El-Aneed, A.1
-
3
-
-
0031962780
-
Polymer-coated long-circulating microparticulate pharmaceuticals
-
Torchilin VP. Polymer-coated long-circulating microparticulate pharmaceuticals. J Microencapsul 1998;15:1-19.
-
(1998)
J Microencapsul
, vol.15
, pp. 1-19
-
-
Torchilin, V.P.1
-
4
-
-
0032580354
-
Drug delivery and targeting
-
Langer R. Drug delivery and targeting. Nature (Lond.) 1998;392 (Suppl.):5-10.
-
(1998)
Nature (Lond.)
, vol.392
, Issue.SUPPL.
, pp. 5-10
-
-
Langer, R.1
-
5
-
-
25844524902
-
Polymer-drug conjugates: Towards a novel approach for the treatment of endrocine-related cancer
-
Duncan R, Vicent MJ, Greco F, Nicholson RI. Polymer-drug conjugates: towards a novel approach for the treatment of endrocine-related cancer. Endocr Relat Cancer 2005;12 (Suppl 1): S189-99.
-
(2005)
Endocr Relat Cancer
, vol.12
, Issue.SUPPL. 1
-
-
Duncan, R.1
Vicent, M.J.2
Greco, F.3
Nicholson, R.I.4
-
6
-
-
0041181628
-
HPMA copolymer-anticancer drug conjugates: Design, activity, and mechanism of action
-
Kopecek J, Kopeckova P, Minko T, Lu Z. HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action. Eur J Pharm Biopharm 2000;50:61-81.
-
(2000)
Eur J Pharm Biopharm
, vol.50
, pp. 61-81
-
-
Kopecek, J.1
Kopeckova, P.2
Minko, T.3
Lu, Z.4
-
7
-
-
36849067019
-
Nanocarriers as an emerging platform for cancer therapy
-
Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007;2:751-60.
-
(2007)
Nat Nanotechnol
, vol.2
, pp. 751-760
-
-
Peer, D.1
Karp, J.M.2
Hong, S.3
Farokhzad, O.C.4
Margalit, R.5
Langer, R.6
-
8
-
-
33747840618
-
Polymer conjugates as anticancer nanomedicines
-
Duncan R. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer 2006;6:688-701.
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 688-701
-
-
Duncan, R.1
-
9
-
-
0025148495
-
Disposition characteristics of macromolecules in tumor-bearing mice
-
Takakura Y, Fujita T, Hashida M, Sezaki H. Disposition characteristics of macromolecules in tumor-bearing mice. Pharm Res 1990;7: 339-46.
-
(1990)
Pharm Res
, vol.7
, pp. 339-346
-
-
Takakura, Y.1
Fujita, T.2
Hashida, M.3
Sezaki, H.4
-
10
-
-
0026926609
-
Conjugates of anticancer agents and polymers: Advantages of macromolecular therapeutics in vivo
-
Maeda H, Seymour LW, Miyamoto Y. Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. Bioconjug Chem 1992;3:351-62.
-
(1992)
Bioconjug Chem
, vol.3
, pp. 351-362
-
-
Maeda, H.1
Seymour, L.W.2
Miyamoto, Y.3
-
11
-
-
0024508158
-
Activity of N-(2-hydroxypropyl)methacrylamide copolymers containing daunomycin against a rat tumour model
-
Cassidy J, Duncan R, Morrison GJ, Strohalm J, Plocova D, Kopecek J, Kaye SB. Activity of N-(2-hydroxypropyl)methacrylamide copolymers containing daunomycin against a rat tumour model. Biochem. Pharmacol 1989;38:875-9.
-
(1989)
Biochem. Pharmacol
, vol.38
, pp. 875-879
-
-
Cassidy, J.1
Duncan, R.2
Morrison, G.J.3
Strohalm, J.4
Plocova, D.5
Kopecek, J.6
Kaye, S.B.7
-
12
-
-
0028337034
-
Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice
-
Yamaoka T, Tabata Y, Ikada Y. Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice. J Pharm Sci 1994;83:601-6.
-
(1994)
J Pharm Sci
, vol.83
, pp. 601-606
-
-
Yamaoka, T.1
Tabata, Y.2
Ikada, Y.3
-
13
-
-
0033137321
-
Transduced p16INK4a peptides inhibit hypophosphorylation of the retinoblastoma protein and cell cycle progression prior to activation of Cdk2 complexes in late G1
-
Gius DR, Ezhevsky SA, Becker-Hapak M, Nagahara H, Wei MC, Dowdy SF. Transduced p16INK4a peptides inhibit hypophosphorylation of the retinoblastoma protein and cell cycle progression prior to activation of Cdk2 complexes in late G1. Cancer Res 1999;59: 2577-80.
-
(1999)
Cancer Res
, vol.59
, pp. 2577-2580
-
-
Gius, D.R.1
Ezhevsky, S.A.2
Becker-Hapak, M.3
Nagahara, H.4
Wei, M.C.5
Dowdy, S.F.6
-
14
-
-
0036554868
-
Trojan p16 peptide suppresses pancreatic cancer growth and prolongs survival in mice
-
Hosotani R, Miyamoto Y, Fujimoto K, Doi R, Otaka A, Fujii N, Imamura M. Trojan p16 peptide suppresses pancreatic cancer growth and prolongs survival in mice. Clin Cancer Res 2002;8:1271-6.
-
(2002)
Clin Cancer Res
, vol.8
, pp. 1271-1276
-
-
Hosotani, R.1
Miyamoto, Y.2
Fujimoto, K.3
Doi, R.4
Otaka, A.5
Fujii, N.6
Imamura, M.7
-
15
-
-
0031025385
-
Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21WAF1
-
Ball KL, Lain S, Fahraeus R, Smythe C, Lane DP. Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21WAF1. Curr Biol 1997;7:71-80.
-
(1997)
Curr Biol
, vol.7
, pp. 71-80
-
-
Ball, K.L.1
Lain, S.2
Fahraeus, R.3
Smythe, C.4
Lane, D.P.5
-
16
-
-
0030615324
-
p21WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth
-
Bonfanti M, Taverna S, Salmona M, D'Incalci M, Broggini M. p21WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth. Cancer Res 1997;57:1442-6.
-
(1997)
Cancer Res
, vol.57
, pp. 1442-1446
-
-
Bonfanti, M.1
Taverna, S.2
Salmona, M.3
D'Incalci, M.4
Broggini, M.5
-
17
-
-
84984621304
-
Temperature of Polypeptide Inverse Temperature Transition Depends on Mean Residue Hydrophobicity
-
Urry DW, Luan C-H, Parker TM, Gowda DC, Prasad KU, Reid MC, Safavy A. Temperature of Polypeptide Inverse Temperature Transition Depends on Mean Residue Hydrophobicity. J Am Chem Soc. 1991;113:4346-8.
-
(1991)
J Am Chem Soc
, vol.113
, pp. 4346-4348
-
-
Urry, D.W.1
Luan, C.-H.2
Parker, T.M.3
Gowda, D.C.4
Prasad, K.U.5
Reid, M.C.6
Safavy, A.7
-
18
-
-
0034326357
-
Elastomeric proteins: Biological roles, structures and mechanisms
-
Tatham AS, Shewry PR. Elastomeric proteins: biological roles, structures and mechanisms. Trends Biochem Sci 2000;25:567-71.
-
(2000)
Trends Biochem Sci
, vol.25
, pp. 567-571
-
-
Tatham, A.S.1
Shewry, P.R.2
-
19
-
-
0035866357
-
Targeting a Genetically Engineered Elastin-like Polypeptide to Solid Tumors by Local Hyperthermia
-
Meyer DE, Kong GA, Dewhirst MW, Zalutsky MR, Chilkoti A. Targeting a Genetically Engineered Elastin-like Polypeptide to Solid Tumors by Local Hyperthermia. Cancer Res 2001;61:1548-54.
-
(2001)
Cancer Res
, vol.61
, pp. 1548-1554
-
-
Meyer, D.E.1
Kong, G.A.2
Dewhirst, M.W.3
Zalutsky, M.R.4
Chilkoti, A.5
-
20
-
-
33845223376
-
Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude mice
-
Liu W, Dreher MR, Furgeson DY, Peixoto KV, Yuan H, Zalutsky MR, Chilkoti A. Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude mice. J Control Release 2006;116:170-8.
-
(2006)
J Control Release
, vol.116
, pp. 170-178
-
-
Liu, W.1
Dreher, M.R.2
Furgeson, D.Y.3
Peixoto, K.V.4
Yuan, H.5
Zalutsky, M.R.6
Chilkoti, A.7
-
21
-
-
34249316870
-
Thermal cycling enhances the accumulation of a temperature-sensitive biopolymer in solid tumors
-
Dreher MR, Liu W, Michelich CR, Dewhirst MW, Chilkoti A. Thermal cycling enhances the accumulation of a temperature-sensitive biopolymer in solid tumors. Cancer Res 2007;67:4418-24.
-
(2007)
Cancer Res
, vol.67
, pp. 4418-4424
-
-
Dreher, M.R.1
Liu, W.2
Michelich, C.R.3
Dewhirst, M.W.4
Chilkoti, A.5
-
22
-
-
0025144298
-
Effects of hyperthermia, radiotherapy and thermoradiotherapy on tumor microvascular permeability
-
Fujiwara K, Watanabe T. Effects of hyperthermia, radiotherapy and thermoradiotherapy on tumor microvascular permeability. Acta Pathol Jpn 1990;40:79-84.
-
(1990)
Acta Pathol Jpn
, vol.40
, pp. 79-84
-
-
Fujiwara, K.1
Watanabe, T.2
-
23
-
-
0022317917
-
Effect of hyperthermia on microvascular permeability to macromolecules in normal and tumor tissues
-
Gerlowski LE, Jain RK. Effect of hyperthermia on microvascular permeability to macromolecules in normal and tumor tissues. Int J Microcirc Clin Exp 1985;4:363-72.
-
(1985)
Int J Microcirc Clin Exp
, vol.4
, pp. 363-372
-
-
Gerlowski, L.E.1
Jain, R.K.2
-
24
-
-
0023481357
-
Transport of molecules across tumor vasculature
-
Jain RK. Transport of molecules across tumor vasculature. Cancer Metastasis Rev 1987;6:559-93.
-
(1987)
Cancer Metastasis Rev
, vol.6
, pp. 559-593
-
-
Jain, R.K.1
-
26
-
-
19344365470
-
Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide
-
Snyder EL, Meade BR, Saenz CC, Dowdy SF. Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide. PLoS Biol 2004;2:E36.
-
(2004)
PLoS Biol
, vol.2
-
-
Snyder, E.L.1
Meade, B.R.2
Saenz, C.C.3
Dowdy, S.F.4
-
27
-
-
13944258970
-
Intracellular targeting of polymer-bound drugs for cancer chemotherapy
-
Nori A, Kopecek J. Intracellular targeting of polymer-bound drugs for cancer chemotherapy. Adv Drug Deliv Rev 2005;57:609-36.
-
(2005)
Adv Drug Deliv Rev
, vol.57
, pp. 609-636
-
-
Nori, A.1
Kopecek, J.2
-
28
-
-
9644289511
-
The use of cell-penetrating peptides for drug delivery
-
Temsamani J, Vidal P. The use of cell-penetrating peptides for drug delivery. Drug Discov Today 2004;9:1012-19.
-
(2004)
Drug Discov Today
, vol.9
, pp. 1012-1019
-
-
Temsamani, J.1
Vidal, P.2
-
29
-
-
27744525788
-
Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery
-
Massodi I, Bidwell GL, 3rd, Raucher D. Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery. J Control Release 2005;108:396-408.
-
(2005)
J Control Release
, vol.108
, pp. 396-408
-
-
Massodi, I.1
Bidwell 3rd, G.L.2
Raucher, D.3
-
30
-
-
35648978993
-
A thermally responsive Tat-elastin-like polypeptide fusion protein induces membrane leakage, apoptosis, and cell death in human breast cancer cells
-
Massodi I, Raucher D. A thermally responsive Tat-elastin-like polypeptide fusion protein induces membrane leakage, apoptosis, and cell death in human breast cancer cells. J Drug Target 2007; 15:611-22.
-
(2007)
J Drug Target
, vol.15
, pp. 611-622
-
-
Massodi, I.1
Raucher, D.2
-
31
-
-
33846510441
-
Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin
-
Bidwell GL, 3rd, Fokt I, Priebe W, Raucher D. Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin. Biochem Pharmacol 2007;73:620-31.
-
(2007)
Biochem Pharmacol
, vol.73
, pp. 620-631
-
-
Bidwell 3rd, G.L.1
Fokt, I.2
Priebe, W.3
Raucher, D.4
-
32
-
-
0037016020
-
Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7
-
Sadler K, Eom KD, Yang JL, Dimitrova Y, Tam JP. Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7. Biochemistry 2002;41:14150-7.
-
(2002)
Biochemistry
, vol.41
, pp. 14150-14157
-
-
Sadler, K.1
Eom, K.D.2
Yang, J.L.3
Dimitrova, Y.4
Tam, J.P.5
-
33
-
-
61649103094
-
Targeting a c-Myc inhibitory polypeptide to specific intracellular compartments using cell penetrating peptides
-
Bidwell GL, 3rd, Davis AN, Raucher D. Targeting a c-Myc inhibitory polypeptide to specific intracellular compartments using cell penetrating peptides. J Control Release 2009;135:2-10.
-
(2009)
J Control Release
, vol.135
, pp. 2-10
-
-
Bidwell 3rd, G.L.1
Davis, A.N.2
Raucher, D.3
-
34
-
-
0033565263
-
A p21(Waf1/Cip1)carboxyl-terminal peptide exhibited cyclin-dependent kinase-inhibitory activity and cytotoxicity when introduced into human cells
-
Mutoh M, Lung FD, Long YQ, Roller PP, Sikorski RS, O'Connor PM. A p21(Waf1/Cip1)carboxyl-terminal peptide exhibited cyclin-dependent kinase-inhibitory activity and cytotoxicity when introduced into human cells. Cancer Res 1999;59:3480-8.
-
(1999)
Cancer Res
, vol.59
, pp. 3480-3488
-
-
Mutoh, M.1
Lung, F.D.2
Long, Y.Q.3
Roller, P.P.4
Sikorski, R.S.5
O'Connor, P.M.6
-
35
-
-
0029257341
-
A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen
-
Warbrick E, Lane DP, Glover DM, Cox LS. A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen. Curr Biol 1995;5:275-82.
-
(1995)
Curr Biol
, vol.5
, pp. 275-282
-
-
Warbrick, E.1
Lane, D.P.2
Glover, D.M.3
Cox, L.S.4
-
36
-
-
0037130974
-
Design of thermally responsive, recombinant polypeptide carriers for targeted drug delivery
-
Chilkoti A, Dreher MR, Meyer DE. Design of thermally responsive, recombinant polypeptide carriers for targeted drug delivery. Adv Drug Deliv Rev 2002;54:1093-111.
-
(2002)
Adv Drug Deliv Rev
, vol.54
, pp. 1093-1111
-
-
Chilkoti, A.1
Dreher, M.R.2
Meyer, D.E.3
-
37
-
-
23144442466
-
Application of thermally responsive polypeptides directed against c-Myc transcriptional function for cancer therapy
-
Bidwell GL, 3rd, Raucher D. Application of thermally responsive polypeptides directed against c-Myc transcriptional function for cancer therapy. Mol Cancer Ther 2005;4:1076-85.
-
(2005)
Mol Cancer Ther
, vol.4
, pp. 1076-1085
-
-
Bidwell 3rd, G.L.1
Raucher, D.2
-
38
-
-
0032739304
-
Purification of Recombinant Proteins by Fusion with Thermally Responsive Polypeptides
-
Meyer DE, Chilkoti A. Purification of Recombinant Proteins by Fusion with Thermally Responsive Polypeptides. Nat Biotechnol 1999;17:1112-15.
-
(1999)
Nat Biotechnol
, vol.17
, pp. 1112-1115
-
-
Meyer, D.E.1
Chilkoti, A.2
-
39
-
-
33644856596
-
Mechanistic and functional studies of the interaction of a proline-rich antimicrobial peptide with mammalian cells
-
Tomasinsig L, Skerlavaj B, Papo N, Giabbai B, Shai Y, Zanetti M. Mechanistic and functional studies of the interaction of a proline-rich antimicrobial peptide with mammalian cells. J Biol Chem 2006; 281:383-91.
-
(2006)
J Biol Chem
, vol.281
, pp. 383-391
-
-
Tomasinsig, L.1
Skerlavaj, B.2
Papo, N.3
Giabbai, B.4
Shai, Y.5
Zanetti, M.6
-
40
-
-
0035325262
-
Inhibition of cell proliferation by the PCNA-binding region of p21 expressed as a GFP miniprotein
-
Mattock H, Lane DP, Warbrick E. Inhibition of cell proliferation by the PCNA-binding region of p21 expressed as a GFP miniprotein. Exp Cell Res 2001;265:234-41.
-
(2001)
Exp Cell Res
, vol.265
, pp. 234-241
-
-
Mattock, H.1
Lane, D.P.2
Warbrick, E.3
-
41
-
-
0033514441
-
Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation
-
Brugarolas J, Moberg K, Boyd SD, Taya Y, Jacks T, Lees JA. Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation. Proc Natl Acad Sci USA 1999;96:1002-7.
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, pp. 1002-1007
-
-
Brugarolas, J.1
Moberg, K.2
Boyd, S.D.3
Taya, Y.4
Jacks, T.5
Lees, J.A.6
-
42
-
-
33748047128
-
RB and cell cycle progression
-
Giacinti C, Giordano A. RB and cell cycle progression. Oncogene 2006;25:5220-7.
-
(2006)
Oncogene
, vol.25
, pp. 5220-5227
-
-
Giacinti, C.1
Giordano, A.2
-
43
-
-
1642433090
-
p53-independent induction of p21(waf1/cip1) contributes to the activation of caspases in GTP-depletion-induced apoptosis of insulin-secreting cells
-
Huo JX, Metz SA, Li GD. p53-independent induction of p21(waf1/cip1) contributes to the activation of caspases in GTP-depletion-induced apoptosis of insulin-secreting cells. Cell Death Differ 2004; 11:99-109.
-
(2004)
Cell Death Differ
, vol.11
, pp. 99-109
-
-
Huo, J.X.1
Metz, S.A.2
Li, G.D.3
-
44
-
-
29144445979
-
Enhancing the antiproliferative effect of topoisomerase II inhibitors using a polypeptide inhibitor of c-Myc
-
Bidwell GL, 3rd, Raucher D. Enhancing the antiproliferative effect of topoisomerase II inhibitors using a polypeptide inhibitor of c-Myc. Biochem Pharmacol 2006;71:248-56.
-
(2006)
Biochem Pharmacol
, vol.71
, pp. 248-256
-
-
Bidwell 3rd, G.L.1
Raucher, D.2
-
45
-
-
34250620539
-
A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance
-
Bidwell GL, 3rd, Davis AN, Fokt I, Priebe W, Raucher D. A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance. Invest New Drugs 2007;25:313-26.
-
(2007)
Invest New Drugs
, vol.25
, pp. 313-326
-
-
Bidwell 3rd, G.L.1
Davis, A.N.2
Fokt, I.3
Priebe, W.4
Raucher, D.5
-
46
-
-
33748648777
-
Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells
-
Tunnemann G, Martin RM, Haupt S, Patsch C, Edenhofer F, Cardoso MC. Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells. Faseb J 2006; 20: 1775-84.
-
(2006)
Faseb J
, vol.20
, pp. 1775-1784
-
-
Tunnemann, G.1
Martin, R.M.2
Haupt, S.3
Patsch, C.4
Edenhofer, F.5
Cardoso, M.C.6
-
47
-
-
0029063745
-
Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1
-
Luo Y, Hurwitz J, Massague J. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature 1995;375:159-61.
-
(1995)
Nature
, vol.375
, pp. 159-161
-
-
Luo, Y.1
Hurwitz, J.2
Massague, J.3
-
48
-
-
0036594890
-
The role of the cyclin-dependent kinase inhibitor p21 in apoptosis
-
Gartel AL, Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 2002;1:639-49.
-
(2002)
Mol Cancer Ther
, vol.1
, pp. 639-649
-
-
Gartel, A.L.1
Tyner, A.L.2
-
49
-
-
33847384130
-
A sychnological cell penetrating peptide mimic of p21(WAF1/CIP1) is proapoptogenic
-
Baker RD, Howl J, Nicholl ID. A sychnological cell penetrating peptide mimic of p21(WAF1/CIP1) is proapoptogenic. Peptides 2007; 28:731-40.
-
(2007)
Peptides
, vol.28
, pp. 731-740
-
-
Baker, R.D.1
Howl, J.2
Nicholl, I.D.3
|